Transforming Transfusion Diagnostics.
Quotient has a wide range of CE marked monoclonal ABO and RhD blood grouping antisera, including rare monoclonal blood grouping antisera and a selection of Polyclonal Antisera.
Quotient has a wide range of CE marked monoclonal ABO and RhD blood grouping antisera. The cell lines from which these are derived have been widely tested and evaluated by reference centres throughout the world and at international workshops.
Click for Brochure
These conventional blood grouping antisera are suitable for use by IAT. Many of these reagents may be suitable for use by other techniques, e.g. column agglutination. However users must validate suitability of techniques before use. The majority of these polyclonal antisera are derived from donations of human antiserum exclusive to Quotient.
Click for Brochure
Quotient has a wide range of rare monoclonal blood grouping antisera manufactured and standardised in accordance with UKBTS Guidelines which comply with the provisions of the European Union in vitro Diagnostic Medical Devices Directive.
Click for BrochureJERSEY, Channel Islands, April 16, 2015 (G…Continue »
Quotient has launched an e-learning website p… Continue »